Clinical Trial

Dobutamine During Major Abdominal Surgery

Study acronym: PUSH-1
Completed
View on ClinicalTrials.gov →
Summary
The PUSH-1 trial is a randomized, single-center pilot trial investigating whether dobutamine administration is feasible in patients having major abdominal surgery.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-05-22; most recent amendment 2026-04-27.
Status change: Recruiting → Completed 2026-04-27
Status change: Not Yet Recruiting → Recruiting 2025-06-16
Trial Details
NCT Number NCT07000994
Lead Sponsor University of Hamburg-Eppendorf
Conditions Intraoperative Myocardial Depression
Enrollment 100 participants
Start Date 2025-06-16
Primary Completion 2026-01-28 (estimated)
Study Completion 2026-02-27 (estimated)
Updated on ClinicalTrials.gov 2026-04-29